Wells Syndrome in Children: Case Study and Differential Diagnostics
https://doi.org/10.15690/vsp.v19i6.2156
Abstract
Clinical Case Description. The clinical case of Wells syndrome in female 4 years old patient is presented. Clinical findings included symmetrical skin lesions, nodes and large irregular edematous plaques of red-purple color with clear fluid vesicles on its surface. The disease had wavy course: rashes have recovered spontaneously over 7–10 days, new elements appeared alongside with feeling unwell, fever up to 37,8°C and abdominal pain. Similar clinical findings of rashes were observed in paternal relatives of the child.
Conclusion. Differential diagnostics of Wells syndrome should be carried out with skin granulomatous diseases and hypereosinophilic syndrome that may be characterized by similar clinical findings. Verification of Wells syndrome diagnosis is complicated due to its rareness, low awareness of dermatologists and pediatricians about this pathology, as well as ignoring the need to carry out histological tests during the disease exacerbation.
About the Authors
Nikolay N. MurashkinRussian Federation
Moscow
Disclosure of interest:
Nikolay N. Murashkin — receiving research grants from pharmaceutical companies Jansen, Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma PLC. Scientific consultant of Galderma, Pierre Fabre, Bayer, LEO Pharma, Pfizer, AbbVie
Eduard T. Ambarchian
Russian Federation
Moscow
Disclosure of interest:
Eduard T. Ambarchian — receiving research grants from pharmaceutical companies Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma PLC. Scientific consultant of Johnson & Johnson company
Roman V. Epishev
Russian Federation
Moscow
Disclosure of interest:
Alexander I. Materikin, Roman V. Epishev — receiving research grants from pharmaceutical companies Eli Lilly, Novartis
Alexander I. Materikin
Russian Federation
Moscow
Disclosure of interest:
Alexander I. Materikin, Roman V. Epishev — receiving research grants from pharmaceutical companies Eli Lilly, Novartis
Leonid A. Opryatin
Russian Federation
Moscow
Disclosure of interest:
The other contributors confirmed the absence of a reportable conflict of interests
Roman A. Ivanov
Russian Federation
Moscow
Disclosure of interest:
The other contributors confirmed the absence of a reportable conflict of interests
Daria S. Kukoleva
Russian Federation
Moscow
Disclosure of interest:
The other contributors confirmed the absence of a reportable conflict of interests
References
1. Sinno H, Lacroix J.-P, Lee J, et al. Diagnosis and management of eosinophilic cellulitis (Wells’ syndrome): A case series and literature review. Can J Plast Surg. 2012;20(2):91–97. doi: 10.1177/229255031202000204.
2. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57(1):46–56.
3. Wells GC, Smith NP. Eosinophilic cellulitis. Br J Dermatol. 1979; 100(1):101–109. doi: 10.1111/j.1365-2133.1979.tb03574.x.
4. Weins AB, Biedermann T, Weiss T, Weiss JM. Wells syndrome. J Dtsch Dermatol Ges. 2016;14(10):989–993. doi: 10.1111/ddg.13132.
5. Rajpara A, Liolios A, Fraga G, Blackmon J. Recurrent paraneoplastic Wells syndrome in a patient with metastatic renal cell cancer. Dermatol Online J. 2014; 20(6): 13030/qt35w8r1g3.
6. Murat O., Ucan E., Ibiloglu I. Eosinophilic Cellulitis Successfully Treated with Colchicine. Indian Dermatol Online J. 2019;10(4): 467–468. doi: 10.4103/idoj.IDOJ_387_18.
7. Yu AM, Ito S, Leibson T, et al. Pediatric Wells syndrome (eosinophilic cellulitis) after vaccination: A case report and review of the literature. Pediatr Dermatol. 2018;35(5):e262–e264. doi: 10.1111/pde.13532.
8. Heelan K, Ryan JF, Shear NH, Egan CA. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep. 2013;7(4): 113–120. doi: 10.3315/jdcr.2013.1157.
9. Silva CMR, Ottoni FA, Andrade-Filho JS, et al. Do you know this syndrome? An Bras Dermatol. 2007;82:575–578.
10. Brasileiro LG, de Abreu MAMM, Paschoal RS. Wells’ syndrome: the importance of differential diagnosis. An Bras Dermatol. 2019; 94(3):370–372. doi: 10.1590/abd1806-4841.20197840.
11. Aberer W, Konrad K, Wolff K. Wells’ syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Derm. 1988;18(1 Pt 1):105–114. doi: 10.1016/s0190-9622(88)70016-x.
12. Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: A report of 19 cases. Arch Dermatol. 2006; 142(9):1157–1161. doi: 10.1001/archderm.142.9.1157.
13. Ghosh S, Bhattacharya M, Dhar S. Churg-Strauss syndrome. Indian J Dermatol. 2011;56(6):718–721. doi: 10.4103/0019-5154.91836.
14. Herchline TE, Swaminathan S, Chandrasekar PH, Bronze MS. Cellulitis. Upd.: Jun 14, 2019. Available online: https://emedicine.medscape.com/article/214222. Accessed on 10 October, 2020.
15. Mitchell AJ, Anderson TF, Headington JT, Rasmussen JE. Recurrent granulomatous dermatitis with eosinophilia. Wells’ syndrome. Int J Dermatol. 1984;23(3):198–202. doi: 10.1111/j.1365-4362.1984.tb04511.x.
16. Bogenrieder T, Griese DP, Schiffner R, et al. Wells’ syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol. 1997;137(6):978–982.
17. Qiao J, Sun CE, Zhu W, et al. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease? Int J Exp Pathol. 2013;6(8): 1683–1687.
18. Powell J, Kaur M, Muc R, et al. Persistent hypereosinophilia with Wells syndrome. Clin Exp Dermatol. 2012;38(1):40–43. doi: 10.1111/j.1365-2230.2012.04370.x.
19. Verma P, Singal A, Sharma S. Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination. Indian J Dermatol Venereol Leprol. 2012;78:378–380.
20. Gilliam AE, Bruckner AL, Howard RM, et al. Bullous “cellulitis” with eosinophilia: case report and review of Wells’ syndrome in childhood. Pediatrics. 2005;116(1):e149–e155. doi: 10.1542/peds.2004-2273.
21. Iglesias Puzas A, Mesa Alvarez L, Florez Menendez A, et al. Wells’ Syndrome Successfully Treated with Colchicine. Case Rep Dermatol. 2017;9(2):65–69. doi: 10.1159/000477756.
22. Herout S, Bauer WM, Schuster C, Stingl G. Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab. JAAD Case Rep. 2018;4(6):548–550. doi: 10.1016/j.jdcr.2018.02.011.
Review
For citations:
Murashkin N.N., Ambarchian E.T., Epishev R.V., Materikin A.I., Opryatin L.A., Ivanov R.A., Kukoleva D.S. Wells Syndrome in Children: Case Study and Differential Diagnostics. Current Pediatrics. 2020;19(6):490-495. (In Russ.) https://doi.org/10.15690/vsp.v19i6.2156